InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by White Mark Andrew. Officer active across 1 company, notably Rocket Pharmaceuticals, INC.. Aggregated, 5 reports have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €388k. Activity tracked since 4 April 2023. The latest transaction was filed on 31 October 2024 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
White Mark Andrew is a declarant linked to Rocket Pharmaceuticals, INC. (XNAS), where the listed role is See Remarks. He has 5 filings in total, and across the sampled recent filings between 2023-04-12 and 2024-11-04, the activity consists of sales, with total sell volume of EUR 388351 and no buys.